Point72 Asset Management
TNXP icon

Point72 Asset Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Point72 Asset Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9M Buy
1,166,752
+1,041,338
+830% +$13.4M 0.02% 1044
2026
Q1 		$1.72M Sell
125,414
-494,619
-80% -$7.61M ﹤0.01% 2419
2025
Q4 		$9.68M Buy
+620,033
New +$11.4M 0.01% 1376
2025
Q1 		– Sell
-15,963
Closed -$526K – 2538
2024
Q4 		$526K Buy
+15,963
New +$332K ﹤0.01% 1653

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Point72 Asset Management's TNXP Position: Q2 2026 in Review

Point72 Asset Management increased its Tonix Pharmaceuticals (TNXP) stake by 830% in Q2 2026, buying an estimated $13.4M and bringing the position to 1,166,752 shares worth $14.9M. The position accounts for 0.02% of the portfolio, ranked #1044.

Point72 Asset Management first reported a position in TNXP in Q4 2024 and has held it in 4 quarters since. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Point72 Asset Management held 1,166,752 shares of Tonix Pharmaceuticals worth $14.9M as of Q2 2026.
  • Point72 Asset Management bought 1,041,338 Tonix Pharmaceuticals shares in Q2 2026, an estimated $13.4M.
  • Tonix Pharmaceuticals made up 0.02% of Point72 Asset Management's portfolio in Q2 2026, its #1044 holding.
  • Point72 Asset Management first reported a position in Tonix Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.